Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain

Abstract

<p class="first" id="d1044472e451">Joint pain is the defining symptom of osteoarthritis (OA) but its origin and mechanisms remain unclear. Here, we investigated an unprecedented role of osteoclast-initiated subchondral bone remodeling in sensory innervation for OA pain. We show that osteoclasts secrete netrin-1 to induce sensory nerve axonal growth in subchondral bone. Reduction of osteoclast formation by knockout of receptor activator of nuclear factor kappa-B ligand ( <i>Rankl</i>) in osteocytes inhibited the growth of sensory nerves into subchondral bone, dorsal root ganglion neuron hyperexcitability, and behavioral measures of pain hypersensitivity in OA mice. Moreover, we demonstrated a possible role for netrin-1 secreted by osteoclasts during aberrant subchondral bone remodeling in inducing sensory innervation and OA pain through its receptor DCC (deleted in colorectal cancer). Importantly, knockout of <i>Netrin1</i> in tartrate-resistant acid phosphatase–positive (TRAP-positive) osteoclasts or knockdown of <i>Dcc</i> reduces OA pain behavior. In particular, inhibition of osteoclast activity by alendronate modifies aberrant subchondral bone remodeling and reduces innervation and pain behavior at the early stage of OA. These results suggest that intervention of the axonal guidance molecules (e.g., netrin-1) derived from aberrant subchondral bone remodeling may have therapeutic potential for OA pain. </p><p class="first" id="d1044472e463"> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/91e14232-c8df-4ae6-bd01-cb9ba2a635c2/PubMedCentral/image/jci-129-121561-g104.jpg"/> </div> </p>